ALL
-
-
Aug 01, 2024 M&A/partnership
-
-
M&A/partnership
-
Conclusion of Business Alliance with PHARUMO, Inc(254 KB)
-
-
Jul 25, 2024 stock
-
-
stock
-
Notice Regarding Disposal of Treasury Stock as Restricted Stock Compensation(206 KB)
-
-
Jul 24, 2024 M&A/partnership
-
-
M&A/partnership
-
Announcement of Investment in Hirosaki Lifescience Innovation, Inc.(290 KB)
-
-
Jul 23, 2024 stock
-
-
stock
-
Notice Concerning Change of Major Shareholders(241 KB)
-
-
Jun 27, 2024 corporate
-
-
corporate
-
Notice Regarding Change of Representative Directors(70 KB)
-
-
Jun 27, 2024 corporate
-
-
corporate
-
Notice Regarding Executive Appointment(114 KB)
-
-
Jun 14, 2024 product/service
-
-
product/service
-
Notice Regarding Launch of 3 Ingredients / 8 Products of Generic Drugs for KYOSOMIRAI PHARMA(162 KB)
-
-
Jun 14, 2024 product/service
-
-
product/service
-
Notice Regarding Change of Trade Names for 2 Ingredients and 3 Products Manufactured and Sold by the Company(103 KB)
-
-
Jun 07, 2024 other
-
-
other
-
Notice Regarding Relocation of Head Office Location(89 KB)
-
-
May 10, 2024 performance
-
-
performance
-
Consolidated Financial Results for the Fiscal Year Ended March 31, 2024(591 KB)
-
-
May 10, 2024 stock
-
-
stock
-
Announcement about Adjustment of Conversion Price for Zero Coupon Convertible Bonds due 2028(219 KB)
-
-
Apr 30, 2024 performance
-
-
performance
-
Notice Regarding the Revision of the Full-year Earnings Forecasts for the Fiscal Year Ended March 2024(142 KB)
-
-
Apr 05, 2024 corporate
-
-
corporate
-
Notice Regarding Decision on the Candidates for Directors(144 KB)
-
-
Apr 05, 2024 stock
-
-
stock
-
Notice regarding Revision of Restricted Stock Compensation Plan(198 KB)
